Studies have pointed out that miR-200b is highly expressed in plasma-derived exosomes from patients with ovarian cancer, and it promotes the proliferation and invasion of ovarian cancer cells by inhibiting the expression of KLF6 to induce the polarization of macrophages M2 [50]. Here, KLF6 is linked to ovarian carcinoma.